drugset / Trial / NCT05455112
Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is proposed to evaluate the safety and efficacy of the RUTI vaccine in patients with pulmonary tuberculosis. Therapeutic vaccination of RUTI would stimulate the immune response not only against growing bacteria, but also against bacteria in a latent state that are less sensitive to antibiotic treatments. Therapeutic vaccination in patients with pulmonary tuberculosis could improve the speed of recovery of patients without inducing the appearance of drug resistance.
Timeline
- Start
- 2022-10-29
- Primary completion
- 2024-10-30
- Completion
- 2024-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RUTI | Vaccine | 25 ug | Subcutaneous |